Diabetes: Moving toward a more individualized approach.
New and emerging treatment plans are abandoning long-held ideas and becoming much more targeted to diabetes patients' individual needs. But a personalized approach could make quality measurement and pay-for-performance more complicated, and they will need to change, too.
Geri
G
Aston
D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000628:therapy*; D004032:Diet; D004359:Drug Therapy, Combination; D004864:Equipment and Supplies; D006442:Glycated Hemoglobin; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010347:Patient Care Planning / Q000458:organization & administration*; D011787:Quality of Health Care / Q000458:organization & administration*; D012052:Reimbursement, Incentive
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents